Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Head & Neck 7Genitourinary 4Lymphoid 3Endocrine 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1Other 1Myeloid 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Mouth Neoplasms 1Fanconi Anemia 1

Interventions

Cyclophosphamide 79fludarabine phosphate 75Busulfan 53Whole-Body Irradiation 51Mycophenolic Acid 50Cyclosporine 47Peripheral Blood Stem Cell Transplantation 46fludarabine 42Antilymphocyte Serum 37Melphalan 36Tacrolimus 35Filgrastim 30Cord Blood Stem Cell Transplantation 27Radiotherapy 23Methotrexate 22Cytarabine 22Methylprednisolone 19Granulocyte Colony-Stimulating Factor 18apixaban 17Thiotepa 17Dalteparin 13thymoglobulin 12Rivaroxaban 12Alemtuzumab 12eltrombopag 11ferric carboxymaltose 10Surveys and Questionnaires 10Etoposide 10Epoetin Alfa 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ethanol × Classical hematology × Clear all
NCT05973656 2025-08-22

Role of Acetaldehyde in the Development of Oral Cancer

Masonic Cancer Center, University of Minnesota

Phase NA Recruiting
170 enrolled
Classical hematologyHead & Neck

Fanconi Anemia, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡